RNS Number : 5856H
CAP-XX Limited
14 November 2025
14 November 2025
CAP-XX Limited
("CAP-XX" or "the Company")
Issue of Shares and Director/PDMR Shareholding
Consistent with the Company's previous announcements regarding the issue of ordinary shares in lieu of certain directors' fees, and in line with the Company's ongoing strategy to preserve its cash resources, CAP-XX announces that it has today issued 7,303,025 ordinary shares in the Company ("New Ordinary Shares"), in lieu of certain fees for Dr Graham Cooley, Chairman. The New Ordinary Shares have been issued at a price of 0.275 pence, being the closing mid-market price of the Company's shares on 13 November 2025.
The New Ordinary Shares being issued have been allocated to the following director of CAP-XX:
Director
New Ordinary Shares issued at 0.275p
Total number of ordinary shares now held
% of enlarged ordinary share capital now held
Dr Graham Cooley
7,303,025
610,306,425
10.53%
Application will be made for the New Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur on or around 20 November 2025. Following Admission, the Company's issued share capital will consist of 5,797,326,778 ordinary shares of no par value. The above figure of 5,797,326,778 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.
The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation, is appended further below.
For further information contact:
CAP-XX Limited
Dr Graham Cooley (Chairman) +61 (2) 9157 0000
Lars Stegmann (Chief Executive Officer)
Allenby Capital (Nominated Adviser and Broker)
David Hart/Piers Shimwell (Corporate Finance) +44 (0) 20 3328 5656
Jos Pinnington/Tony Quirke (Sales and Corporate Broking)
Notes to Editors:
CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high-power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics and deliver similar benefits in automotive and other transportation applications.
For more information about CAP-XX, visit www.cap-xx.com
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
1) Dr Graham Cooley
2
Reason for the notification
a)
Position/status
1) Non-Executive Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CAP-XX Limited
b)
LEI
213800HECUSIYXH3WN26
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument Identification code
Ordinary shares of no par value each in CAP-XX Limited Identification code (ISIN) for CAP-XX Limited ordinary shares:AU0000XINAS1
b)
Nature of the transaction
Shares issued in lieu of salary
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1)
0.275pence per ordinary share
7,303,025ordinary shares
d)
Aggregated information - Aggregated volume - Price
Single transaction as in 4 c) above.
e)
Date of the transaction
13 November 2025
f)
Place of the transaction
Outside of trading venue - issue of new ordinary shares
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBIBFTMTBBMPA
